Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Head & Neck 2Genitourinary 2Gastrointestinal 2Dermatologic 2Lymphoid 1Gynecologic 1Breast 1

Conditions

Carcinoma, Renal Cell 17Melanoma 16Kidney Neoplasms 11Neoplasm Metastasis 10Uterine Cervical Neoplasms 9Prostatic Neoplasms 9Breast Neoplasms 7Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Anus Neoplasms 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Penile Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Lymphoma 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Vulvar Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Wilms Tumor 2

Interventions

pembrolizumab 16Nivolumab 9atezolizumab 7Docetaxel 7Cyclophosphamide 5durvalumab 4Ipilimumab 4Gemcitabine 4avelumab 3Specimen Handling 3Radiotherapy 3Psychiatric Rehabilitation 3Magnetic Resonance Spectroscopy 3Etoposide 3Carboplatin 3temsirolimus 2spartalizumab 2sargramostim 2fludarabine 2epacadostat 2enzalutamide 2cabozantinib 2aldesleukin 2abiraterone 2Therapeutics 2Standard of Care 2Radiosurgery 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × fludarabine × Genitourinary × Clear all
NCT03841110 2023-05-01

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Fate Therapeutics

Phase 1 Completed
37 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

NCT04596033 2022-07-15

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Genocea Biosciences, Inc.

Phase 1 Terminated
49 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡